| Application no. and date | 22209104.3 (espacenet) (Federated) (European Patent Register), 20111220 | | Patent/reg. no. and date | DK/EP 4159204, 20240214 | | Publication date | 20230405 | | Priority no. and date | US 201061424967 P, 20101220 | | EP pub. no. and date |
EP 4159204 20230405 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P3077DKEP02 | | Inventor | LE, Ngocdiep T.,
Collegeville, PA, 19426, US,
HENRIQUEZ, Francisco,
Collegeville, PA, 19426, US,
WANG, Lihong,
Collegeville, PA, 19426, US,
DE MARINI, Douglas, J.,
Collegeville, PA, 19426, US | | Representative | Aera A/S, Niels Hemmingsens Gade 10, 1153 København K, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61P 35/00 (2006.01) | | Title | Hidtil ukendt farmaceutisk sammensætning | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
